K-ras mutations in patients with early colorectal cancers

Gut

Volumn 41, Issue 3, 1997, Pages 323-329

  Andreyev, H J N ^a,b   Tilsed, J V T ^d   Cunningham, D ^a   Sampson, S A ^c   Norman, A R ^a   Schneider, H J ^a   Clarke, P A ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Royal Marsden Hospital   (United Kingdom)

^d KENT AND SUSSEX HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Dukes' stage; K ras; Microdissection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030800498     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.3.323     Document Type: Article

References (34)

1. Smith LE. Colorectal cancer: surgical treatment. In: Ahlgren JD, MacDonald JD, eds. Gastrointestinal oncology. Philadelphia: JB Lippincott, 1992: 327-38.
2. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
3. International multicentre pooled analysis of colon cancer trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345: 939-44.
4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525-32.
5. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9
6. Kinoshita T, Yokota T, Arai K, Miyajima A. Regulation of BCL2 expression by oncogenic ras protein in haematopoietic cells. Oncogene 1995; 10: 2207-12.
7. Vojtek AB, Cooper JA. Rho family members: activators of the MAP kinase cascades. Cell 1995; 82: 527-9.
8. Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988; 239: 645-7.
9. Sklar MD. Increased resistance to cis diamminedichloroplatinum(II) In NIH 3T3 cells transformed by ras oncogenes [published erratum appears in Cancer Res 1988; 48: 3889]. Cancer Res 1988; 48: 793-7.
10. Schwab G, Duroux I, Chavany C, Helene C, Saison Behmoaras E. An approach for new anticancer drugs: oncogene targeted antisense DNA. Ann Oncol 1994; 5 (suppl 4): 55-8.
11. Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Specific inhibition of K ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 1991 51: 1744-8.
12. Oudejans JJ, Slebos RJ, Zoetmulder FA, Mooi WJ, Rodenhuis S. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer 1991; 49: 875-9.
13. Halter SA, Webb L, Rose J. Lack of ras mutations and prediction of long-term survival in carcinoma of the colon. Mod Pathol 1992; 5: 131-4.
14. Suchy B, Zietz C, Rabes HM. K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metasases. Int J cancer 1992; 52: 30-3.
15. Benhattar J, Losi L, Chaubert P, Givel JC, Costa J. Prognostic significance of K ras mutations in colorectal carcinoma. Gastroenterology 1993; 104: 1044-8.
16. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Cancer 1993; 71: 3827-38.
17. Moerkerk P, Arends JW, Van Driel M, De Bruine A, De Goeij A, Ten Kate J. Type and number of Ki ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994; 54: 3376-8.
18. Tanaka M, Omura K, Watanabe Y, Oda Y, Nakanishi I. Prognostic factors of colorectal cancer: K ras mutation, overexpression of the p53 protein and cell proliferative activity. J Surg Oncol 1994; 57: 57-64.
19. Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ. The common molecular genetic alterations in Dukes B and C colorectal carcinomas are not short term prognostic indicators of survival. Int J Cancer 1994; 59: 747-51.
20. Morrin M, Kelly M, Barrett N, Delaney P. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut 1994; 35: 1627-31.
21. Bennett MA, Kay EW, Mulcahy H, O'Flaherty L, O'Donaghue DP, Leader M, et al. Ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. J Clin Pathol: Mol Pathol 1995; 48: M310-5.
22. Kato M, Ito Y, Kobayashi S, Isono R. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence. Cancer 1996; 77: 1729-35.
23. Kasrinakis WV, Ramchurren N, Mahggard M, Steele G, Summerhayes IC. K ras status does not predict successful hepatic resection of colorectal metastasis. Arch Surg 1995; 130: 9-14.
24. Markovitz S, Hines JD, Lutterbaugh J, Myeroff L, Mackay W, Gordon K, et al. Mutant K ras oncogenes in colon cancer do not predict patient's chemotherapy response or survival. Clin Cancer Res 1995; 1: 441-5.
25. Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. K ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer 1994; 69: 367-71.
26. Urosevic N, Krtolica K, Skaro Milic A, Knezevic Usaj S, Dujic A. Prevalence of G to T transversions among K ras oncogene mutations in human colorectal tumors in Yugoslavia. Int J Cancer 1993; 54: 249-54.
27. Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H. Infrequent K ras activation in superficial type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 1994; 54: 2841-4.
28. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c Ki ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990; 99: 416-20.
29. Sambrook J, Fritsch EF, Maniatis T (eds). Molecular cloning. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989: E3-4
30. McGrath JP, Capon DJ, Smith DH, et al. Structure and organisation of the human Ki ras proto oncogene and a related processed pseudogene. Nature 1983; 304: 501-6.
31. Shimizu K, Birnbaum D, Ruley MA, Fasano O, Suard Y, Edlund L, et al. Structure of the Ki ras gene of the human lung carcinoma cell line Calu1. Nature 1983; 304: 497-500.
32. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991; 19: 4008.
33. Minamoto T, Yamashita N, Ochiai A, Mai M, Sugimura T, Ronai Z, et al. Mutant K-ras in apparently normal mucosa in colorectal cancer patients. Cancer 1995; 75: 1520-5.
34. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds). American Joint Commission on Cancer. Manual for staging cancer. 4th edn. Philadelphia: JB Lippincott, 1992: 76.